Abstracts

Filters

Clear Filters
All Days Sun, Sep 27 Mon, Sep 28 Tue, Sep 29 Wed, Sep 30

Monday, September 28

11:45 AM - 11:55 AM ET

Discussant
Speaker: Daly, Megan, MD - University of California, Irvine, Irvine, CA
1:30 PM - 1:40 PM ET

1 - Hypofractionated vs. Conventional Fractionated Postmastectomy Radiotherapy in High-Risk Breast Cancer: 10-Year Outcomes from a Phase 3 Randomized Trial
Speaker: Sun, Guang-Yi, MD - National Cancer Center/Cancer Hospital, Chinese Academy of Medical Science and Peking Union Medical, Beijing, Beijing
1:40 PM - 1:50 PM ET

2 - Initial Results of NRG Oncology NRG-GI003: A Phase III Randomized Trial of Protons vs. Photons for Hepatocellular Carcinoma (HCC)
Speaker: Hong, Theodore, MD - Dana-Farber Cancer Institute, Boston, Massachusetts
1:50 PM - 2:00 PM ET

LBA 01 - Alliance A071801 Phase III Trial Postoperative Single Fraction Stereotactic Radiosurgery (SRS) vs. Fractionated SRS (fSRS) for Resected Brain Metastasis
Speaker: Aizer, Ayal, MD - Brigham and Women's Hospital, Boston, MA
2:00 PM - 2:10 PM ET

LBA 02 - NRG-CC009: A Phase III Trial of Stereotactic Radiosurgery (SRS) vs. Hippocampal-Avoidant Whole Brain Radiotherapy (HA-WBRT) for Brain Metastases from Small Cell Lung Cancer (SCLC)
Speaker: Rusthoven, Chad, MD - University of Colorado School of Medicine, Aurora, COLORADO
3:00 PM - 3:10 PM ET

210 - Atezolizumab and Stereotactic Body Radiation in Metastatic, Recurrent, or Persistent Cervical Cancer: Long Term Results and Biomarker Analysis from a Phase II Multi-Institutional Study
Speaker: Ahmed, Kamran, MD - H. Lee Moffitt Cancer Center, Tampa, FL
3:00 PM - 3:10 PM ET

215 - Gut-Derived Short-Chain Fatty Acids Orchestrate Tumor Metabolic and T-cell Immune Reprogramming to Potentiate Radiotherapy Efficacy in Head and Neck Cancer
Speaker: Then, Chee Kin, MD, PhD - Shuang Ho Hospital, Taipei Medical University, New Taipei City, Taipei
3:00 PM - 3:10 PM ET

221 - Nivolumab and Ipilimumab with or without Stereotactic Body Radiation in Advanced or Recurrent Merkel Cell Carcinoma: Long Term Results and Biomarker Analysis from a Phase II Multi-Institutional Study
Speaker: Kim, Sungjune, MD, PhD - Mayo Clinic Florida, Jacksonville, FL
3:00 PM - 4:00 PM ET

Adaptive Radiation Therapy
Speaker: Gu, Xuejun, PhD - Stanford University School of Medicine, Stanford, CA
3:00 PM - 4:00 PM ET

Adaptive Radiation Therapy
Speaker: Price, Michael, PhD, MS, DABR FAAPM - Columbia University Irving Medical Center, New York, NY
3:00 PM - 4:00 PM ET

CNS Metastases and LMD: Patient Selection, Treatment Strategy and Outcomes
Speaker: Breen, William, MD - Mayo Clinic Rochester, Rochester, Minnesota
3:00 PM - 4:00 PM ET

CNS Metastases and LMD: Patient Selection, Treatment Strategy and Outcomes
Speaker: Yang, Jonathan, MD, PhD - New York University School of Medicine, New York, NY